康龍化成(300759.SZ)擬向康龍天津、康龍紹興和寧波科技增資合計12.75億元
格隆匯1月9日丨康龍化成(300759.SZ)公佈,康龍化成(天津)藥物製備技術有限公司(下稱“康龍天津”)、康龍化成(紹興)藥業有限公司(下稱“康龍紹興”)是公司全資子公司,康龍化成持有其100%的股權。康龍化成(寧波)科技發展有限公司(下稱“寧波科技”)是康龍化成和康龍化成(寧波)新藥技術有限公司(下稱“康龍寧波”)的子公司,康龍化成直接持有其61.54%的股權,康龍寧波持有其38.46%的股權,康龍寧波是康龍化成的全資子公司,公司持有其100%的股權。為優化康龍天津、康龍紹興、寧波科技的資產負債結構,加強市場競爭力,促進其業務發展,公司擬以自有資金向康龍天津、康龍紹興和寧波科技公司進行增資。
康龍天津增資金額為人民幣2.00億元,本次增資後康龍天津公司註冊資本由4.20億元增加到6.20億元。康龍紹興增資金額為人民幣3.00億元,本次增資後康龍紹興公司註冊資本由1.00億元增加到4.00億元。寧波科技增資金額為人民幣7.75億元,本次增資後寧波科技公司註冊資本由3.25億元增加到11.00億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.